Lugui Qiu

25PUBLICATIONS
119CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersTissue engineeringMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 30, 2026
A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies.

|Sep 30, 2026
Treatment Patterns and Clinical Outcomes Among Chinese Patients With Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Study (CHAMP-MM).

|Sep 07, 2026
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

|Jun 27, 2026
Bispecific antibody engineered extracellular vesicles redirect T cells to prevent postoperative epidural fibrosis.

|Mar 30, 2026
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.

Yuting Yan, Weihao Chen, Ying Yu

|Mar 21, 2026
Pharmacodynamic evaluation and mechanism study of cord blood nucleated cell extract in the treatment of rheumatoid arthritis.

Rui Guo, Junye Yang, Hechen Zhang

Pageof 5

Frequent Collaborators

11 joint publications

Gang An

9 joint publications

Shuhua Yi

9 joint publications

Yan Xu

8 joint publications

Jian Cui